Neovasc is a medical device company that develops, manufactures and markets products for the cardiovascular marketplace. Its products include Neovasc Reducer™, which is a treatment for patients with refractory angina, a condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle, despite treatment with standard revascularization or cardiac drug therapies; and Tiara™, which is a product for treating mitral valve disease.